Paul R. Kemp

6.8k citations

122 papers · 5.1k indexed · h-index 41

Molecular Biology top 5%
Physiology top 2%
Pulmonary and Respiratory Medicine top 2%
Cancer Research top 2%
Cardiology and Cardiovascular Medicine top 5%

Co-authors: James C. Metcalfe Michael I. Polkey David J. Grainger Nicholas S Hopkinson Richard M. Lawn John Moxham William D‐C Man Samantha A. Natanek
Topics: Nutrition and Health in Aging (28 papers)Chronic Obstructive Pulmonary Disease (COPD) Research (25 papers)Muscle Physiology and Disorders (18 papers)
Cited by: Cancer Research Physiology Immunology and Allergy
Journals: Nature Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: United Kingdom United States South Sudan

In The Last Decade

Paul R. Kemp

120 papers receiving 4.9k citations

Peers

Countries citing papers authored by Paul R. Kemp

Since Specialization

Citations

This map shows the geographic impact of Paul R. Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul R. Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul R. Kemp more than expected).

Fields of papers citing papers by Paul R. Kemp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul R. Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul R. Kemp. The network helps show where Paul R. Kemp may publish in the future.

Co-authorship network of co-authors of Paul R. Kemp

This figure shows the co-authorship network connecting the top 25 collaborators of Paul R. Kemp. A scholar is included among the top collaborators of Paul R. Kemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul R. Kemp. Paul R. Kemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patterns and mechanisms of wetland change in the Breton sound estuary, Mississippi River delta: A review 2024 ·Estuarine Coastal and Shelf Science ·John W. Day,Robert R. Lane,(unknown),H. C. Clark,Mead A. Allison,Ehab Meselhe,Alexander S. Kolker,Rachael Hunter,Paul R. Kemp,Jae-Young Ko,Robert R. Twilley,John R. White,R. D. DeLaune,(unknown),(unknown),(unknown),(unknown)	2
2	The validity of Engagement and Feedback Assessments (EFAs): identifying students at risk of failing 2023 ·BMC Medical Education ·Paul R. Kemp,(unknown),(unknown),Daniel Davies,Mary J. Morrell,Amir H. Sam	0
3	Hypereosinophilia during dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps 2023 ·Rhinology Journal ·Paul R. Kemp,(unknown),(unknown),(unknown),Linda B. L. Benoist,Marjolein Cornet,(unknown),(unknown),(unknown),Wytske J. Fokkens,Sietze Reitsma	13
4	Leucine and perindopril to improve physical performance in people over 70 years with sarcopenia: the LACE factorial RCT 2022 ·SHILAP Revista de lepidopterología ·Miles D. Witham,Simon J. Adamson,Alison Avenell,Margaret Band,Tufail Bashir,Peter T. Donnan,George Casella,Adrian Hapca,(unknown),Paul R. Kemp,Emma McKenzie,(unknown),Christos Rossios,Karen Smith,Allan D. Struthers,Deepa Sumukadas	2
5	EGF receptor (EGFR) inhibition promotes a slow-twitch oxidative, over a fast-twitch, muscle phenotype 2019 ·Scientific Reports ·(unknown),(unknown),(unknown),Mark J. Paul‐Clark,Saffron A.G. Willis‐Owen,Miriam F. Moffatt,William Cookson,Jane A. Mitchell,Michael I. Polkey,Simon M. Hughes,Paul R. Kemp,Samantha A. Natanek	17
6	Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial): study protocol for a randomised controlled trial 2018 ·Trials ·Margaret Band,Deepa Sumukadas,Allan D. Struthers,Alison Avenell,Peter T. Donnan,Paul R. Kemp,Karen Smith,(unknown),Adrian Hapca,Miles D. Witham	33
7	MicroRNA-542 Promotes Mitochondrial Dysfunction and SMAD Activity and Is Elevated in Intensive Care Unit–acquired Weakness 2017 ·American Journal of Respiratory and Critical Care Medicine ·(unknown),Richard Paúl,(unknown),Amy Lewis,Benjamin Garfield,Samantha A. Natanek,Susannah Bloch,Vincent Mouly,Mark Griffiths,Michael I. Polkey,Paul R. Kemp	62
8	Muscle Regeneration after Critical Illness: Are Satellite Cells the Answer? 2016 ·American Journal of Respiratory and Critical Care Medicine ·Michael I. Polkey,Mark Griffiths,Paul R. Kemp	7
9	Klotho expression is reduced in COPD 2013 ·European Respiratory Journal ·Mehul S. Patel,Amy Lewis,Samantha A. Natanek,Dario Martolini,P. L. B. Bruijnzeel,Vladimir Anikin,(unknown),Simon Jordan,Nicholas S Hopkinson,William D‐C Man,Paul R. Kemp,Michael I. Polkey	1
10	MuRF-1 and Atrogin-1 Protein Expression and Quadriceps Fiber Size and Muscle Mass in Stable Patients with COPD 2013 ·COPD Journal of Chronic Obstructive Pulmonary Disease ·Samantha A. Natanek,Joanna Riddoch‐Contreras,(unknown),Nicholas S Hopkinson,John Moxham,William D‐C Man,Paul R. Kemp,Michael I. Polkey	22
11	Pathways associated with reduced quadriceps oxidative fibres and endurance in COPD 2012 ·European Respiratory Journal ·Samantha A. Natanek,Harry R. Gosker,Ilse G.M. Slot,(unknown),Nicholas S Hopkinson,John Moxham,Paul R. Kemp,Annemie M.W.J. Schols,Michael I. Polkey	26
12	Investigating circulating microRNAs as potential biomarkers of quadriceps weakness in COPD 2011 ·European Respiratory Journal ·Anna Donaldson,Amy Lewis,Samantha A. Natanek,William D‐C Man,Paul R. Kemp,Michael I. Polkey	2
13	Expresión y localización del factor de transcripción Yin Yang 1 en el músculo cuádriceps en la enfermedad pulmonar obstructiva crónica 2011 ·Archivos de Bronconeumología ·Samantha A. Natanek,Joanna Riddoch‐Contreras,(unknown),Nicholas S Hopkinson,William D‐C Man,John Moxham,Michael I. Polkey,Paul R. Kemp	17
14	KLF13 influences multiple stages of both B and T cell development 2008 ·Cell Cycle ·Susan V. Outram,Adele Gordon,Ariadne L. Hager‐Theodorides,James C. Metcalfe,Tessa Crompton,Paul R. Kemp	23
15	Aspectos socioeconómicos y biofísicos de la desertificación 2005 ·LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) ·James F. Reynolds,Fernando T. Maestre,Elisabeth Huber‐Sannwald,Jeffrey E. Herrick,Paul R. Kemp	20
16	Regulated Tissue-specific Alternative Splicing of Enhanced Green Fluorescent Protein Transgenes Conferred by α-Tropomyosin Regulatory Elements in Transgenic Mice 2004 ·Journal of Biological Chemistry ·Peter Ellis,Christopher W. J. Smith,Paul R. Kemp	40
17	Expression of Klf9 and Klf13 in mouse development 2001 ·Mechanisms of Development ·(unknown),James C. Metcalfe,Paul R. Kemp	28
18	Molecular cloning of the human HAND2 gene 1998 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Mark W. Russell,Paul R. Kemp,Lihong Wang,Lawrence C. Brody,Seigo Izumo	18
19	Expression and distribution of transforming growth factor-β isoforms and their signaling receptors in growing human bone 1998 ·Bone ·A Horner,Paul R. Kemp,Charlotte Summers,S Bord,Nicolette C. Bishop,A. Kelsall,Nick Coleman,Juliet Compston	103
20	ACTIVATION OF TRANSFORMING GROWTH-FACTOR-BETA IS INVERSELY CORRELATED WITH 3 MAJOR RISK-FACTORS FOR CORONARY-ARTERY DISEASE - LIPOPROTEIN(A), LDL-CHOLESTEROL AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 1994 ·UCL Discovery (University College London) ·(unknown),NR Williams,J. C. Metcalfe,AA Grace,(unknown),(unknown),Paul R. Kemp,(unknown),(unknown)	1

About Paul R. Kemp

Paul R. Kemp is a scholar working on Physiology, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine, having authored 122 papers that have together received 5.1k indexed citations. Recurring topics across this work include Nutrition and Health in Aging (28 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (25 papers) and Muscle Physiology and Disorders (18 papers). The work is most often cited by research in Cancer Research (647 citations), Physiology (1.1k citations) and Immunology and Allergy (227 citations). Paul R. Kemp has collaborated with scholars based in United Kingdom, United States and South Sudan. Frequent co-authors include James C. Metcalfe, Michael I. Polkey, David J. Grainger, Nicholas S Hopkinson, Richard M. Lawn, John Moxham, William D‐C Man, Samantha A. Natanek, Susannah Bloch and Mark Griffiths. Their work appears in journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact